HIGH PLASMA CONCENTRATIONS OF β-RECEPTOR BLOCKING DRUGS AND DEFICIENT DEBRISOQUINE HYDROXYLATION
- 6 February 1982
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 319 (8267) , 333
- https://doi.org/10.1016/s0140-6736(82)91583-5
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Prazosin first dose phenomenon during combined treatment with a beta- adrenoceptor blocker in hypertensive patients.British Journal of Clinical Pharmacology, 1982
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981
- Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver.Published by Wiley ,1981
- A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.Journal of Medical Genetics, 1980
- Pharmacokinetic and Pharmacodynamic Properties of Metoprolol in Patients with Impaired Renal FunctionClinical Pharmacokinetics, 1980
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977
- Value of Anion-Gap Determination in Multiple MyelomaNew England Journal of Medicine, 1977
- Metabolism of metoprolol‐(3H) in man, the dog and the ratActa Pharmacologica et Toxicologica, 1975
- The Possible Role of Cytochrome P‐450 in the Liver “First Pass Elimination” of a P‐Receptor Blocking DrugActa Pharmacologica et Toxicologica, 1974